(S (NP-SBJ-42 (JJ Protein-tyrosine) (NN kinase) (NN activation)) (VP (VBZ is) (VP (VBN required) (NP (-NONE- *-42)) (PP (IN for) (NP-COOD (NP (NP (NN lipopolysaccharide) (NN induction)) (PP (IN of) (NP (NN interleukin) (NN 1beta)))) (CC and) (NP (NN NFkappaB) (NN activation)) (, ,) (CONJP (CC but) (RB not)) (NP (NN NFkappaB) (JJ nuclear) (NN translocation)))))) (. .))
(S (PP (IN In) (NP (JJ human) (NNS monocytes))) (, ,) (NP-SBJ-COOD-43 (NP (NN interleukin) (NN 1beta) (NN protein) (NN production)) (CC and) (NP (JJ steady) (NN state) (NN mRNA) (NNS levels))) (VP (VBP are) (VP (VBN increased) (NP (-NONE- *-43)) (PP (IN in) (NN response) (TO to) (NP (NN lipopolysaccharide))) (, ,) (PP (ADVP (RB predominantly)) (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (VBN increased) (NN transcription)) (PP (IN of) (NP (DT the) (NN interleukin) (NN 1beta) (NN gene))))))))) (. .))
(S (NP-SBJ-44 (NP (NN Expression)) (PP (IN of) (NP-COOD (NP (NN interleukin) (NN 1beta)) (CC and) (NP (NP (JJ other) (NNS cytokines)) (, ,) (PP (JJ such) (IN as) (NP-COOD (NP (NN interleukin) (CD 6)) (CC and) (NP (NN tumor) (NN necrosis) (NN factor) (NN alpha)))) (, ,))))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (NP-SBJ (-NONE- *-44)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (DT the) (NN transcription) (NN factor)) (, ,) (NP (NN NFkappaB))))))))))))) (. .))
(S (SBAR (IN Since) (S (NP-SBJ (JJ recent) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP-SBJ-45 (JJ lipopolysaccharide-induced) (NN tyrosine) (NN kinase) (NN activation)) (VP (VBZ is) (RB not) (VP (VBN required) (NP (-NONE- *-45)) (PP (IN for) (NP (NN NFkappaB) (JJ nuclear) (NN translocation))))))))))) (, ,) (NP-SBJ-46 (PRP we)) (VP (VBD sought) (S (NP-SBJ (-NONE- *-46)) (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP-SBJ-47 (NP (NN NFkappaB)) (VP (VBN translocated) (NP (-NONE- *)) (PP (IN in) (DT the) (NN absence) (IN of) (NP (NN tyrosine) (NN kinase) (NN activity))))) (VP (VBD was) (ADJP-PRD (JJ active)) (PP (IN in) (S (NP-SBJ (-NONE- *-47)) (VP (VBG stimulating) (NP (NN transcription)))))))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN found) (SBAR (IN that) (, ,) (S (PP (IN in) (NP (NP (DT the) (JJ human) (JJ pro-monocytic) (NN cell) (NN line)) (, ,) (NP (NN THP-1)))) (, ,) (NP-SBJ (NP (DT the) (JJ lipopolysaccharide-induced) (NN expression)) (PP (IN of) (NP (NN interleukin) (NN 1beta)))) (VP (VBZ is) (ADJP-PRD (JJ dependent) (PP (IN on) (NP (NN tyrosine) (NN kinase) (NN activation))))))))) (. .))
(S (NP-SBJ-48 (NN Tyrosine) (NNS kinases)) (VP (VBP are) (RB not) (VP (VBN required) (NP (-NONE- *-48)) (PP (IN for) (NP (NP (JJ lipopolysaccharide-mediated) (JJ nuclear) (NN translocation)) (PP (IN of) (NP (NN NFkappaB))))))) (. .))
(S (ADVP (RB However)) (, ,) (PP (IN in) (DT the) (NN absence) (IN of) (NP (NN tyrosine) (NN kinase) (NN activity))) (, ,) (NP-SBJ (NP (DT the) (NN ability) (S (-NONE- *ICH*-50))) (PP (IN of) (NP (NN NFkappaB))) (S-50 (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB stimulate) (NP (NN transcription)))))) (VP (VBZ is) (ADJP-PRD (JJ impaired))) (. .))
(S (S (NP-SBJ (NP (DT This) (NN inhibition)) (PP (IN of) (NP (NN transcription)))) (VP (VBZ is) (ADJP-PRD (JJ specific) (PP (IN for) (NP (NN NFkappaB))))) (: ;)) (S (PP (IN in) (DT the) (NN absence) (IN of) (NP (NN tyrosine) (NN kinase) (NN activity))) (, ,) (NP-SBJ-51 (JJ AP-1-dependent) (NN transcription)) (VP (VBZ is) (VP (VBN enhanced) (NP (-NONE- *-51)))) (. .)))
(S (NP-SBJ (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (SBAR (, ,) (S (NP-SBJ (NP (IN while) (JJ lipopolysaccharide-induced)) (PP (NN expression) (NP (IN of) (JJ inflammatory)))) (VP (NNS mediators) (NP (VBZ requires) (NN tyrosine) (NN kinase))))) (NN activity) (NP-SBJ (, ,) (NN tyrosine) (NN kinase)) (VP (NN activity) (VBZ is) (ADJP-PRD (RB not) (PP (JJ obligatory) (NP (IN for) (NN lipopolysaccharide) (NN signal)))))))) (NN transduction))
